spacer gif spacer gif spacer gif spacer gif spacer gif
QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boerner, J. L.
Right arrow Articles by Maihle, N. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boerner, J. L.
Right arrow Articles by Maihle, N. J.

Journal of Cell Science, Vol 113, Issue 6 935-942, Copyright © 2000 by Company of Biologists

JOURNAL ARTICLES

Ras-independent oncogenic transformation by an EGF-receptor mutant

JL Boerner, MJ McManus, GS Martin and NJ Maihle
Tumor Biology Program, Division of Pediatric Hematology/Oncology, Department of Biochemistry, Mayo Clinic Foundation, Rochester, Minnesota 55905, USA. maihle@mayo.edu

Mutations in the ligand-binding domain of the epidermal growth factor receptor have been identified in several types of human cancers, including malignant gliomas. These mutations render signaling by this receptor to be constitutively ligand-independent. In fibroblasts transformed with ligand-independent epidermal growth factor receptor mutants, there is a correlation between the formation of a unique phosphotyrosine protein complex and oncogenic transformation. This phosphoprotein complex includes Grb2, Shc, Sos, tyrosine-phosphorylated form of caldesmon, and two, as yet, unidentified proteins. The presence of Grb2, Shc, and Sos in this complex implicates Ras in ligand-independent signaling by these oncogenic epidermal growth factor receptor mutants. We, therefore, have used retroviral co-infections of cultured primary fibroblasts to determine if Ras activation is required for phosphoprotein complex formation, stress fiber loss, or transformation. As predicted, expression of a dominant-negative Ras mutant (N17Ras) completely abrogates ligand-stimulated soft agar colony growth of primary fibroblasts. In contrast, N17Ras expression has no effect on v-ErbB mediated stress fiber disassembly, soft agar colony growth, or phosphoprotein complex assembly. In addition, our data suggest that ligand-dependent Ras activation may be suppressed by oncogenic v-ErbB expression. Together these observations suggest that oncogenic signaling by v-ErbB does not require Ras activation, and implicate an alternative signal transduction pathway in ligand-independent epidermal growth factor receptor oncogenic signaling.


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
X. Chen and M. D. Resh
Cholesterol Depletion from the Plasma Membrane Triggers Ligand-independent Activation of the Epidermal Growth Factor Receptor
J. Biol. Chem., December 13, 2002; 277(51): 49631 - 49637.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. L. Boerner, A. Danielsen, M. J. McManus, and N. J. Maihle
Activation of Rho Is Required for Ligand-independent Oncogenic Signaling by a Mutant Epidermal Growth Factor Receptor
J. Biol. Chem., January 26, 2001; 276(5): 3691 - 3695.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. J. McManus, J. L. Boerner, A. J. Danielsen, Z. Wang, F. Matsumura, and N. J. Maihle
An Oncogenic Epidermal Growth Factor Receptor Signals via a p21-activated Kinase-Caldesmon-Myosin Phosphotyrosine Complex
J. Biol. Chem., November 3, 2000; 275(45): 35328 - 35334.
[Abstract] [Full Text] [PDF]


© The Company of Biologists Ltd 2000